Key result
Cell-free plasma telomere length showed no significant association with coronary artery disease, but was prolonged in heart failure patients and contributed to a predictive machine learning model.
Why the study?
The association between circulating cell-free plasma telomere length and CAD and HF required exploration.
Does cell-free plasma telomere length (cf-TL) combined with machine learning models improve the classification of CAD and HF in a cardiovascular screening cohort?
Observational (n=518)
No
Does cell-free plasma telomere length (cf-TL) combined with machine learning models improve the classification of CAD and HF in a cardiovascular screening cohort?
Cell-free plasma telomere length is significantly prolonged in heart failure patients and serves as a valuable biomarker for machine learning-based HF classification, but not for CAD.
Answers are grounded in this paper and cite their sources.
cf-TL prolongation should not alter HF diagnostics now; leaves open its value in ML models pending prospective validation.
This retrospective study explored the association between circulating cell-free plasma telomere length (cf-TL) and coronary artery disease (CAD) and heart failure (HF). Data from 518 participants were collected, including clinical and laboratory data. cf-TL was measured in plasma samples and machine learning (ML) classification models were developed to differentiate between CAD, HF and control conditions. Our results showed that cf-TL was significantly prolonged in HF patients compared to controls, but no significant difference was observed between CAD patients and controls. Additionally, cf-TL was significantly correlated with nitric oxide metabolites (NOx) and flow-mediated dilation (FMD), suggesting a potential link with endothelial function. To avoid data leakage and ensure the model captured only relationships relevant to the research question, we utilized a temporal data split, holding out the last year's data for testing (n = 81) and using the remaining data for training (n = 324) and validation (n = 109). The ML models using four variables achieved an area under the curve (AUC) of 0.795 in the validation dataset and 0.717 in the test dataset for CAD classification, and 0.829 in the validation dataset and 0.806 in the test dataset for HF classification. SHAP analysis revealed that cf-TL had minimal impact on the predictions of the CAD model, as indicated by consistently low SHAP values, whereas in the HF model, cf-TL exhibited a broader range of SHAP values, indicating a greater contribution to the model's classification. These findings suggest that cf-TL may play a more prominent role in HF pathophysiology and could serve as a valuable biomarker for predicting HF risk. Further studies are warranted to explore cf-TL's diagnostic and prognostic potential across different cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2024) conducted an observational in Coronary artery disease (CAD) and Heart failure (HF) (n=518). Cell-free plasma telomere length (cf-TL) vs. Controls (shorter cf-TL or no cardiovascular disease) was evaluated on Coronary artery disease (CAD) (p=0.346). Cell-free plasma telomere length showed no significant association with coronary artery disease, but was prolonged in heart failure patients and contributed to a predictive machine learning model.
Synapse has enriched 10 related papers. Consider them for comparative context: